Cargando…

Somatic mutational landscape of AML with inv(16) or t(8;21) identifies patterns of clonal evolution in relapse leukemia

Detalles Bibliográficos
Autores principales:	Sood, Raman, Hansen, Nancy F., Donovan, Frank X., Carrington, Blake, Bucci, Donna, Maskeri, Baishali, Young, Alice, Trivedi, Niraj S., Kohlschmidt, Jessica, Stone, Richard M., Caligiuri, Michael A., Chandrasekharappa, Settara C., Marcucci, Guido, Mullikin, James C., Bloomfield, Clara D., Liu, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679720/ https://www.ncbi.nlm.nih.gov/pubmed/26139325 http://dx.doi.org/10.1038/leu.2015.141

Ejemplares similares

Outcome and prognostic factors of CBF pediatric AML patients with t(8;21) differ from patients with inv(16)
por: Qiu, Kun-yin, et al.
Publicado: (2023)

The ATRA-21 gene-expression model predicts retinoid sensitivity in CEBPA double mutant, t(8;21) and inv(16) AML patients
por: Bolis, Marco, et al.
Publicado: (2019)

A new inducible model for t(8;21) AML
por: Mulloy, James C
Publicado: (2013)

Efficient Methods for Targeted Mutagenesis in Zebrafish Using Zinc-Finger Nucleases: Data from Targeting of Nine Genes Using CompoZr or CoDA ZFNs
por: Sood, Raman, et al.
Publicado: (2013)

PB1836: LOSS OF HETEROZYGOSITY IN AML PATIENTS WITH INV(16)
por: Bessmertniy, Dmitry, et al.
Publicado: (2023)

Genome-wide co-occupancy of AML1-ETO and N-CoR defines the t(8;21) AML signature in leukemic cells
por: Trombly, Daniel J, et al.
Publicado: (2015)

MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR
por: Johnson, Daniel T., et al.
Publicado: (2021)

Clinical, Cytogenetic, and Molecular Findings in Two Cases of Variant t(8;21) Acute Myeloid Leukemia (AML)
por: Wilde, Lindsay, et al.
Publicado: (2019)

LYL1 facilitates AETFC assembly and gene activation by recruiting CARM1 in t(8;21) AML
por: Chen, Qian, et al.
Publicado: (2022)

Multiplexed CRISPR/Cas9-mediated knockout of 19 Fanconi anemia pathway genes in zebrafish revealed their roles in growth, sexual development and fertility
por: Ramanagoudr-Bhojappa, Ramanagouda, et al.
Publicado: (2018)

Identification of a Dynamic Core Transcriptional Network in t(8;21) AML that Regulates Differentiation Block and Self-Renewal
por: Ptasinska, Anetta, et al.
Publicado: (2014)

Up-regulation of BAALC gene may be an important alteration in AML-M2 patients with t(8;21) translocation
por: Qi, Xiaofei, et al.
Publicado: (2008)

Novel Neurovascular Protective Agents: Effects of INV-155, INV-157, INV-159, and INV-161 versus Lipoic Acid and Captopril in a Rat Stroke Model
por: Connell, Barry J., et al.
Publicado: (2012)

A novel de novo TP63 mutation in whole‐exome sequencing of a Syrian family with Oral cleft and ectrodactyly
por: Simpson, Claire L., et al.
Publicado: (2023)

Human ILC1s target leukemia stem cells and control development of AML
por: Caligiuri, Michael, et al.
Publicado: (2023)

GAS6 expression identifies high-risk adult AML patients: potential implications for therapy
por: Whitman, Susan P., et al.
Publicado: (2013)

Celastrol Induces Cell Apoptosis and Inhibits the Expression of the AML1-ETO/C-KIT Oncoprotein in t(8;21) Leukemia
por: Yu, Xianjun, et al.
Publicado: (2016)

Successful Outcome of a Case of Acute Myeloid Leukemia with t(8;21)/AML-ETO Following Langerhans Cell Histiocytosis
por: Meng, Guangqiang, et al.
Publicado: (2019)

RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML
por: Loke, Justin, et al.
Publicado: (2017)

The RUNX1-ETO target gene RASSF2 suppresses t(8;21) AML development and regulates Rac GTPase signaling
por: Stoner, Samuel A., et al.
Publicado: (2020)

Whole-Exome Sequencing for Diagnosis of Turner Syndrome: Toward Next-Generation Sequencing and Newborn Screening
por: Murdock, David R., et al.
Publicado: (2017)

H->inv at ATLAS+CMS
por: Albert, Andreas
Publicado: (2021)

OsINV3 and Its Homolog, OsINV2, Control Grain Size in Rice
por: Deng, Xiaoshu, et al.
Publicado: (2020)

Neuroanatomic, epigenetic, and genetic differences in monozygotic twins discordant for Attention Deficit Hyperactivity Disorder
por: Chen, Yun-Ching, et al.
Publicado: (2017)

Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding
por: Ptasinska, A, et al.
Publicado: (2012)

A novel epigenetic AML1‐ETO/THAP10/miR‐383 mini‐circuitry contributes to t(8;21) leukaemogenesis
por: Li, Yonghui, et al.
Publicado: (2017)

Peptide microarray profiling identifies phospholipase C gamma 1 (PLC-γ1) as a potential target for t(8;21) AML
por: Mahmud, Hasan, et al.
Publicado: (2017)

Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement
por: Zaenker, Stephan, et al.
Publicado: (2011)

MiR-130a is aberrantly overexpressed in adult acute myeloid leukemia with t(8;21) and its suppression induces AML cell death
por: Ding, Chao, et al.
Publicado: (2018)

RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction
por: Ptasinska, Anetta, et al.
Publicado: (2019)

RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction
por: Ptasinska, Anetta, et al.
Publicado: (2019)

A Novel Platform to Test In Vivo Single Gene Dependencies in t(8,21) and t(15,17) AML Confirms Zeb2 as Leukemia Target
por: De Conti, Giulia, et al.
Publicado: (2020)

Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML)
por: Agrawal, Mridul, et al.
Publicado: (2019)

ILC1s Control Leukemia Stem Cell Fate and Limit Development of AML
por: Li, Zhenlong, et al.
Publicado: (2022)

Core‐binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I‐CBFit)
por: Ustun, Celalettin, et al.
Publicado: (2018)

Chidamide inhibits t(8;21) AML cell proliferation and AMK1/ETO and C-KIT expression by inhibiting ERK1/2 signaling pathway
por: Liu, Jing, et al.
Publicado: (2020)

GM AND INV FACTORS IN SUBCLASSES OF HUMAN IGG
por: Terry, William D., et al.
Publicado: (1965)

Homoharringtonine combined with aclarubicin and cytarabine synergistically induces apoptosis in t(8;21) leukemia cells and triggers caspase‐3‐mediated cleavage of the AML1‐ETO oncoprotein
por: Cao, Jiang, et al.
Publicado: (2016)

First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation
por: Dewan, Ramita, et al.
Publicado: (2017)

Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults
por: Young, Andrew L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vqcc1630b32t7jd1r6dnf27tcb